Literature DB >> 9472613

Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.

S Tamura1, T Iwasaki, A H Thompson, H Asanuma, Z Chen, Y Suzuki, C Aizawa, T Kurata.   

Abstract

Antibody-forming cell (AFC) responses in the nasal-associated lymphoid tissue (NALT) of BALB/c mice were examined following intranasal infection, mainly of the upper respiratory tract, with a small volume of influenza virus. The infection induced significant accumulation of T and B cells in NALT, peaking around day 7 post-infection. Virus-specific IgA, IgG and IgM AFC responses were induced, developing from day 5 and peaking at day 7; responses were predominantly IgA and IgG, followed by IgM. At peak, NALT contained the greatest number of IgA AFCs per total cells of the lymphoid tissues examined in the upper respiratory tract. The IgM AFC responses were induced in NALT cell cultures from uninfected mice following in vitro culture with influenza virus, indicating that at least a part of the AFCs in infected mice may have originated from specific B cell precursors in NALT. In parallel with the detection of AFCs in infected mice, virus-specific IgA antibodies appeared in the nasal wash and their appearance correlated well with virus clearance from the nasal area. These results suggest that virus-specific IgA antibodies, produced by IgA AFCs in NALT, play an important role in recovery from infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472613     DOI: 10.1099/0022-1317-79-2-291

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice.

Authors:  B Liang; L Hyland; S Hou
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Route of nutrition influences generation of antibody-forming cells and initial defense to an active viral infection in the upper respiratory tract.

Authors:  Cheryl D Johnson; Kenneth A Kudsk; Kazuhiko Fukatsu; Kathryn B Renegar; Ben L Zarzaur
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

3.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

4.  Teleost skin, an ancient mucosal surface that elicits gut-like immune responses.

Authors:  Zhen Xu; David Parra; Daniela Gómez; Irene Salinas; Yong-An Zhang; Louise von Gersdorff Jørgensen; Rasmus Demuth Heinecke; Kurt Buchmann; Scott LaPatra; J Oriol Sunyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-24       Impact factor: 11.205

5.  B cell response to herpesvirus infection of the olfactory neuroepithelium.

Authors:  Cindy S E Tan; Philip G Stevenson
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

Review 6.  The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms.

Authors:  T D Randall; R E Mebius
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

Review 7.  The evolution of nasal immune systems in vertebrates.

Authors:  Ali Sepahi; Irene Salinas
Journal:  Mol Immunol       Date:  2015-09-19       Impact factor: 4.407

8.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling.

Authors:  Yoshinori Fujimura; Masaharu Takeda; Hidenori Ikai; Ken Haruma; Takeshi Akisada; Tamotsu Harada; Tatsuya Sakai; Masanobu Ohuchi
Journal:  Virchows Arch       Date:  2003-10-10       Impact factor: 4.064

10.  Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.

Authors:  Krystyna Mozdzanowska; Jingqi Feng; Walter Gerhard
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.